Elpen Pharmaceutical Co. Inc. clinical trials
The registry lists 45 studies whose lead sponsor is Elpen Pharmaceutical Co. Inc. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 20, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 45studies on the registry
- 7open to participants now
Get an email when these change. Save the Elpen Pharmaceutical Co. Inc. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
What it is testing
The drugs Elpen Pharmaceutical Co. Inc.’s studies test, most studies first; none is open now — 5 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Colchicine1 in phase 30 open · 1
- 0 open · 1
- Flecainide1 in phase 30 open · 1
- Metoprolol1 in phase 30 open · 1
- Ranolazine1 in phase 30 open · 1
All 45 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 817
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 126
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Elpen Pharmaceutical Co. Inc.
- Elpen Pharmaceutical Co. Inc.45 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 45 of 45.
- Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.Not yet recruitingNCT07352878
- Administration of Fingolimod in Greek Patients With Multiple Sclerosis.Not yet recruitingNCT06949956
- Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.RecruitingNCT06528613
- TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.RecruitingNCT06117722
- QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt.Not yet recruitingNCT06170125
- Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.RecruitingNCT05168215
- Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice.RecruitingNCT05426915
- Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).CompletedNCT06399341
- A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) CombinationCompletedNCT03858348
- AdHerencE to Treatment and quAlity of Life in COPDCompletedNCT03299673
- Carvedilol Vascular Efficacy TrialCompletedNCT01484327
- Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®CompletedNCT01484210Phase 3
- AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.CompletedNCT04835961
- Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)CompletedNCT04831476
- Ezetimibe-Rosuvastatin Evaluation StudyStatus unknownNCT03947866
- Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate TherapyWithdrawnNCT03873584
- Adherence of Iron Succinylate Therapy in PregnancyWithdrawnNCT03873571
- Efficacy and Safety Study of Fluticasone/Salmeterol Administered With ElpenhalerCompletedNCT05459194Not applicable
- Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice.CompletedNCT03033758
- Prospective evAluatIon foR Inhalation Devices StudyCompletedNCT01800994
- Multiple Electrode Aggregometry & Clopidogrel ResistanceCompletedNCT01991093
- Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart FailureWithdrawnNCT03947853
- Bosentan Treatment of Digital Ulcers Related to Systemic SclerosisCompletedNCT02798055
- Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial FibrillationWithdrawnNCT03162120Phase 2/3
- PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENTCompletedNCT03329729
- Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIonCompletedNCT03317262
- Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial FibrillationWithdrawnNCT02614521
- EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in GreeceCompletedNCT02978703
- COMPLliancE and qualiTy of lifE in AsthmaCompletedNCT03300076
- 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori InfectionCompletedNCT02959255Phase 4
- Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial HypertensionWithdrawnNCT03139084
- COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AFWithdrawnNCT02582190Phase 3
- Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical PracticeCompletedNCT03055793
- Clinical Trial in Patients With Hypertension and Left Ventricular DysfunctionCompletedNCT02148991
- LevetIracetam in Patients Being Treated for EpilepsyCompletedNCT02356731
- Atorvastatin Study in Cardiovascular Disease RiskCompletedNCT02392416
- Eplerenone in Heart Failure TreatmentCompletedNCT02344199
- Antiplatelet Therapy Following Stent ImplantationCompletedNCT02051361
- eVAluatIon of OLanzapine TreatmEnTCompletedNCT02006862
- BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) StudyCompletedNCT01708486
- Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular EventsCompletedNCT01770210
- ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticECompletedNCT01772095
- Osteoporosis Screening TrialCompletedNCT01677637
- A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method.CompletedNCT01855659
- ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment)CompletedNCT01475045